NCT05363319 2026-03-18
CEMI-LUNG
Regeneron Pharmaceuticals
Recruiting
Clinical Trials
8 trialsNCT07223411 2025-11-26
Opdualag vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and Peripheral Blood in Unresectable or Metastatic Melanoma
University of Pittsburgh
Recruiting
NCT03836105 2025-10-15
CASE
Regeneron Pharmaceuticals
Completed
NCT07064330 2025-09-10
NGF-GRACE
Instituto de Investigación Biomédica de Salamanca
Recruiting
NCT07061379 2025-09-03
PROMOTING
IRCCS San Raffaele
Recruiting
NCT06269133 2025-08-27
Evaluation of Cemiplimab in Combination With Platinum-Doublet Chemotherapy in First-Line (1L) Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) in Adult United States (US) Patients
Regeneron Pharmaceuticals
Active not recruiting
NCT06532149 2024-08-09
EROS
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Recruiting
NCT05302297 2022-12-13
TOSCA
Sanofi
Completed